Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers

被引:0
|
作者
Bhateja, Priyanka [1 ]
Liu, Xuefeng [2 ]
Baliga, Sujith [3 ]
Gogineni, Emile [3 ]
Jhawar, Sachin [3 ]
Mitchell, Darrion [3 ]
Ma, Sungjun [3 ]
Zhu, Simeng [3 ]
Konieczkowski, David [3 ]
Blakaj, Dukagjin [3 ]
Old, Matthew [4 ]
Rocco, James [4 ]
Bonomi, Marcelo [1 ]
机构
[1] Ohio State Univ, James Canc Ctr, Dept Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Dept Pathol, Columbus, OH USA
[3] Ohio State Univ, James Canc Ctr, Dept Radiat Oncol, Columbus, OH USA
[4] Ohio State Univ, James Canc Ctr, Dept Otolaryngol, Columbus, OH USA
关键词
cellular effect; genomic instability; human papillomavirus; oncogenesis; proto-oncogenes; virus classification; HEAD;
D O I
10.1002/jmv.70086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been under-recognized. We describe a case series of 6 metastatic/locoregionally recurrent HPVOPSCC patients with FGFR alterations. HPVOPSCC presents with distinct pattern of spread both temporally and sites of recurrence compared to non-HPV-related oropharyngeal cancer. Identification and reporting of genomic alterations in HPV are crucial to the understanding of disease biology and could aid in development of novel therapeutics for these patients. In addition, use of circulating tumor DNA may lead to early detection and supplement imaging in the follow up of these patients. Loco-regional treatments may also play a key role in the management of metastatic HPV OPSCC depending on the pattern of presentation. Our case series highlights all these novelties that could lead to better treatment outcomes.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Fibroblast growth factor receptor (FGFR) expression in the perisutural tissues of craniosynostotic rabbits.
    Dunlavey, K. D.
    Mooney, M. P.
    Sciote, J.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B371 - B371
  • [42] Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations
    Ingersoll, RG
    Paznekas, WA
    Tran, AK
    Scott, AF
    Jiang, G
    Jabs, EW
    CYTOGENETICS AND CELL GENETICS, 2001, 94 (3-4): : 121 - 126
  • [43] Fibroblast growth factor receptor (FGFR) promotes progression of cutaneous squamous cell carcinoma
    Khandelwal, Alok R.
    Rong, Xiaohua
    Moore-Medlin, Tara
    Ma, Xiaohua
    Warner, Amelia
    DiGiovanni, John
    Nathan, Cherie-Ann O.
    CANCER RESEARCH, 2017, 77
  • [44] Xenograft models for development of new drugs targeting fibroblast growth factor receptor (FGFR)
    Zhang, Lan
    Zhang, Juan
    Shi, Qian
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck Cancer
    Chae, Young Kwang
    Pai, Sachin G.
    Sun, Peng
    Costa, Ricardo
    Matsangou, Maria
    Agulnik, Mark
    Giles, Francis
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 13 - 19
  • [46] Fragment based drug discovery of selective inhibitors of Fibroblast Growth Factor Receptor (FGFR)
    Saxty, Gordon
    Akkari, R.
    Angibaud, P.
    Arts, J.
    Benderitter, P.
    Berdini, V.
    Bonnet, P.
    Cleasby, A.
    Embrechts, W.
    Freyne, E.
    Gilissen, R.
    King, P.
    Lacrampe, J.
    Ligny, Y.
    Madin, A.
    Mcclue, S.
    Mevellec, L.
    Murray, C. W.
    Newell, H.
    Page, M.
    Papanikos, A.
    Perera, T.
    Querolle, O.
    Rees, D. C.
    Rich, S. J.
    Saalau-Bethell, S. M.
    Sement, E.
    Simmonet, Y.
    Sguires, M.
    Tronel, V.
    Ward, G. A.
    Willems, M.
    Wroblowski, B.
    Thompson, N. T.
    CANCER RESEARCH, 2011, 71
  • [47] Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer
    Fischbach, Anna
    Rogler, Anja
    Erber, Ramona
    Stoehr, Robert
    Poulsom, Richard
    Heidenreich, Axel
    Schneevoigt, Birte-Swantje
    Hauke, Sven
    Hartmann, Arndt
    Knuechel, Ruth
    Veeck, Juergen
    Gaisa, Nadine T.
    HISTOPATHOLOGY, 2015, 66 (05) : 639 - 649
  • [48] INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY
    Lassman, Andrew
    Sepulveda-Sanchez, Juan
    Cloughesy, Timothy
    Gil-Gil, Juan
    Puduvalli, Vinay
    Raizer, Jeffrey
    De Vos, Filip
    Wen, Patrick
    Butowski, Nicholas
    Clement, Paul
    Groves, Morris
    Belda-Iniesta, Cristobal
    Steward, Keith
    Rowsey, Steven
    Ye, Yining
    Roth, Patrick
    NEURO-ONCOLOGY, 2019, 21 : 20 - 20
  • [49] INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY
    Lassman, A. B.
    Sepulveda-Sanchez, J. M.
    Cloughesy, T.
    Gil-Gil, J. M.
    Puduvalli, V. K.
    Raizer, J.
    De Vos, F. Y.
    Wen, P. Y.
    Butowski, N.
    Clement, P.
    Groves, M. D.
    Belda-Iniesta, C.
    Steward, K.
    Moran, S.
    Ye, Y.
    Roth, P.
    NEURO-ONCOLOGY, 2019, 21 : 21 - 22
  • [50] Functional interaction of receptor tyrosine phosphatase, CD148 with fibroblast growth factor receptor (FGFR).
    Tsuboi, N
    Takahashi, K
    Daniel, TO
    Takahashi, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 339A - 339A